CCX771 is one of the ACKR3 modulators described to induce β-arrestin recruitment to the receptor and it was reported to inhibit tumor growth, lung metastasis, and tumor angiogenesis in in vivo tests [49,50]. The gene discussed is ACKR3; the disease is neoplasm.